je.st
news
Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side
2014-08-22 19:40:52| Biotech - Topix.net
Sunesis Pharmaceuticals is nearing a binary event with the top-line data readout of its Phase 3 Valor trial that is expected any day now.
Tags: the
return
side
short
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||